146 related articles for article (PubMed ID: 8828025)
21. [Ebastine in the treatment of seasonal allergic rhinitis].
Il'ina NI; Balabolkin II; Blokhin BM; Goriachkina LA; Kolganova NA; Pampura AN; Sidorenko IV
Ter Arkh; 1998; 70(9):79-81. PubMed ID: 9821236
[TBL] [Abstract][Full Text] [Related]
22. Antihistamines in severe/chronic rhinitis.
Bousquet J
Clin Exp Allergy; 1998 Dec; 28 Suppl 6():49-53. PubMed ID: 9988436
[TBL] [Abstract][Full Text] [Related]
23. A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.
Bousquet J; Gaudaño EM; Palma Carlos AG; Staudinger H
Allergy; 1999 Jun; 54(6):562-8. PubMed ID: 10435469
[TBL] [Abstract][Full Text] [Related]
24. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
Van Cauwenberge P; De Belder T; Sys L
Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis.
Ratner P; Hampel F; Gispert J
Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):111-5. PubMed ID: 12731456
[TBL] [Abstract][Full Text] [Related]
26. Ebastine in perennial allergic rhinitis.
Picado Vallés C; Cadahia García A; Cisteró Bahima A; Cano Cantudo L; Sanz Amaro A; Zayas Sanza JM
Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273
[TBL] [Abstract][Full Text] [Related]
27. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole.
Berkowitz RB; Dockhorn R; Lockey R; Findlay S; Howland WC; Mitchell DQ; Woehler T
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):363-8. PubMed ID: 8612120
[TBL] [Abstract][Full Text] [Related]
28. [Multicenter study of satisfaction with fast-dissolving ebastine, 20 mg/ day, in Mexican patients with allergic rhinitis].
Aguilar D; Arias A; Báez C; González S; Hernández D; Linares FJ; López A; Macías A; Martínez A; Martínez HM; Martínez N; Mogica MD; Paz D; Rojo I; Sánchez A
Rev Alerg Mex; 2009; 56(2):36-40. PubMed ID: 19526952
[TBL] [Abstract][Full Text] [Related]
29. Comparison of azelastine nasal spray and oral ebastine in treating seasonal allergic rhinitis.
Conde Hernández DJ; Palma Aqilar JL; Delgado Romero J
Curr Med Res Opin; 1995; 13(6):299-304. PubMed ID: 8829888
[TBL] [Abstract][Full Text] [Related]
30. [Clinical efficacy of Ebastine under placebo-controlled outdoors clinical study on cedar pollinosis].
Asaka H; Yoshida H; Baba K
Arerugi; 2002 Apr; 51(4):357-63. PubMed ID: 12014026
[TBL] [Abstract][Full Text] [Related]
31. Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience.
Sastre J
J Investig Allergol Clin Immunol; 2020; 30(3):156-168. PubMed ID: 30977465
[TBL] [Abstract][Full Text] [Related]
32. Comparison of ebastine with cetirizine.
Volkerts ER
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):465-6. PubMed ID: 9396983
[No Abstract] [Full Text] [Related]
33. Astemizole in combination with pseudoephedrine in the treatment of seasonal allergic rhinitis.
Simola M; Böss I; Holopainen E; Malmberg H; Ruoppi P; Seppä J; Siivonen L; Suonpää J; Piepponen T
Rhinology; 1996 Mar; 34(1):21-3. PubMed ID: 8739863
[TBL] [Abstract][Full Text] [Related]
34. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
[TBL] [Abstract][Full Text] [Related]
35. Changes in skin-test reactivity do not correlate with clinical efficacy of H1-blockers in seasonal allergic rhinitis.
Bousquet J; Czarlewski W; Cougnard J; Danzig M; Michel FB
Allergy; 1998 Jun; 53(6):579-85. PubMed ID: 9689339
[TBL] [Abstract][Full Text] [Related]
36. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
Antonijoan RM; García-Gea C; Puntes M; Valle M; Esbri R; Fortea J; Barbanoj MJ
Clin Drug Investig; 2007; 27(7):453-61. PubMed ID: 17563125
[TBL] [Abstract][Full Text] [Related]
37. Investigation on the efficacy and tolerance of azelastine (HCL) nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis.
Conde Hernández J; Palma Aguilar JL; Delgado Romero J
Allergol Immunopathol (Madr); 1995; 23(2):51-7. PubMed ID: 8526167
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy and safety of astemizole in the treatment of allergic rhinitis and urticaria: a systematic review with meta-analysis].
Gutiérrez Castrellón P; Ramírez Mayans J; López Pérez G
Rev Alerg Mex; 2005; 52(3):113-26. PubMed ID: 16158785
[TBL] [Abstract][Full Text] [Related]
39. Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels.
Howarth PH; Emanuel MB; Holgate ST
Br J Clin Pharmacol; 1984 Jul; 18(1):1-8. PubMed ID: 6146346
[TBL] [Abstract][Full Text] [Related]
40. Astemizole in perennial allergic rhinitis with seasonal exacerbations: a placebo-controlled double-blind study.
Tanay A; Neuman I
Ann Allergy; 1989 Dec; 63(6 Pt 1):493-4. PubMed ID: 2574549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
